Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/37286| Title: | Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. | |
| Authors: | ||
| Mesh: | ||
| Issue Date: | 2018 | |
| Citation: | Br. J. Cancer.2018 04;(118)8:1056-1061 | |
| Abstract: | Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. Outpatients with cancer should be periodically assessed for VTE risk, for which the Khorana score is commonly recommended. However, it has been questioned whether this tool is sufficiently accurate at identifying patients who should receive thromboprophylaxis. The present work proposes a new index, TiC-Onco risk score to be calculated at the time of diagnosis of cancer, that examines patients' clinical and genetic risk factors for thrombosis. | |
| PMID: | 29588512 | |
| URI: | https://hdl.handle.net/20.500.12530/37286 | |
| Rights: | openAccess | |
| Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos Hospitales > H. U. de Fuenlabrada > Artículos Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos Hospitales > H. U. La Paz > Artículos | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PMC5931103.pdf | 291.51 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.